ISRG vs. ABT, SYK, BSX, MDT, BDX, EW, DXCM, IDXX, RMD, and ZBH
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector.
Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, community ranking, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.
Abbott Laboratories presently has a consensus price target of $120.64, suggesting a potential upside of 12.14%. Intuitive Surgical has a consensus price target of $403.67, suggesting a potential downside of 3.34%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Abbott Laboratories is more favorable than Intuitive Surgical.
In the previous week, Intuitive Surgical had 6 more articles in the media than Abbott Laboratories. MarketBeat recorded 22 mentions for Intuitive Surgical and 16 mentions for Abbott Laboratories. Intuitive Surgical's average media sentiment score of 0.96 beat Abbott Laboratories' score of 0.88 indicating that Abbott Laboratories is being referred to more favorably in the media.
Intuitive Surgical received 95 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.67% of users gave Abbott Laboratories an outperform vote while only 69.07% of users gave Intuitive Surgical an outperform vote.
Abbott Laboratories has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.9% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical has a net margin of 27.16% compared to Intuitive Surgical's net margin of 13.96%. Intuitive Surgical's return on equity of 20.18% beat Abbott Laboratories' return on equity.
Summary
Intuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
